AAAAAA
Results:
1-14
|
Results: 14
Authors:
Takebayashi, Y
Goldwasser, F
Urasaki, Y
Kohlhagen, G
Pommier, Y
Citation: Y. Takebayashi et al., Ecteinascidin 743 induces protein-linked DNA breaks in human colon carcinoma HCT116 cells and is cytotoxic independently of topoisomerase I expression, CLIN CANC R, 7(1), 2001, pp. 185-191
Authors:
Emile, JF
Azoulay, D
Gornet, JM
Lopes, G
Delvart, V
Samuel, D
Reynes, M
Bismuth, H
Goldwasser, F
Citation: Jf. Emile et al., Primary non-Hodgkin's lymphomas of the liver with nodular and diffuse infiltration patterns have different prognoses, ANN ONCOL, 12(7), 2001, pp. 1005-1010
Authors:
Delaloge, S
Yovine, A
Taamma, A
Riofrio, M
Brain, E
Raymond, E
Cottu, P
Goldwasser, F
Jimeno, J
Misset, JL
Marty, M
Cvitkovic, E
Citation: S. Delaloge et al., Ecteinascidin-743: A marine-derived compound in advanced, pretreated sarcoma patients - Preliminary evidence of activity, J CL ONCOL, 19(5), 2001, pp. 1248-1255
Authors:
Levi, F
Giacchetti, S
Zidani, R
Brezault-Bonnet, C
Tigaud, JM
Goldwasser, F
Misset, JL
Citation: F. Levi et al., Chronotherapy of colorectal cancer metastases, HEP-GASTRO, 48(38), 2001, pp. 320-322
Authors:
Goldwasser, F
Misset, JL
Citation: F. Goldwasser et Jl. Misset, Clinical use of oxaliplatin in solid tumors, B CANCER, 88, 2001, pp. S40-S44
Authors:
Gornet, JM
Azoulay, D
Duclos-Vallee, JC
Goldwasser, F
Citation: Jm. Gornet et al., Complete remission of unresectable hepatocellular carcinoma on healthy liver by the combination of aggressive surgery and high-dose-intensity chemotherapy by CPT-11, ANTI-CANC D, 11(8), 2000, pp. 649-652
Authors:
Gornet, JM
Azoulay, D
Levi, F
Yovine, A
Misset, JL
Goldwasser, F
Citation: Jm. Gornet et al., Dramatic tumor response of bulky liver metastases following treatment withCPT-11 and a chronomodulated 4-day infusion of 5-fluorouracil, folinic acid and oxaliplatin every 2 weeks in a colorectal cancer patient, ANTI-CANC D, 11(4), 2000, pp. 263-268
Authors:
Goldwasser, F
Gross-Goupil, M
Tigaud, JM
Di Palma, M
Marceau-Suissa, J
Wasserman, E
Yovine, A
Misset, JL
Cvitkovic, E
Citation: F. Goldwasser et al., Dose escalation of CPT-11 in combination with oxaliplatin using an every two weeks schedule: A phase I study in advanced gastrointestinal cancer patients, ANN ONCOL, 11(11), 2000, pp. 1463-1470
Authors:
Zeghari-Squalli, N
Raymond, E
Cvitkovic, E
Goldwasser, F
Citation: N. Zeghari-squalli et al., Cellular pharmacology of the combination of the DNA topoisomerase I inhibitor SN-38 and the diaminocyclohexane platinum derivative oxaliplatin, CLIN CANC R, 5(5), 1999, pp. 1189-1196
Authors:
Gross, M
Hiesse, C
Kriaa, F
Goldwasser, F
Citation: M. Gross et al., Severe hemolytic uremic syndrome in an advanced ovarian cancer patient treated with carboplatin and gemcitabine, ANTI-CANC D, 10(6), 1999, pp. 533-536
Authors:
Goldwasser, F
Buthaud, X
Gross, M
Bleuzen, P
Cvitkovic, E
Voinea, A
Jasmin, C
Romain, D
Misset, JL
Citation: F. Goldwasser et al., Decreased topotecan platelet toxicity with successive topotecan treatment cycles in advanced ovarian cancer patients, ANTI-CANC D, 10(3), 1999, pp. 263-265
Authors:
Goldwasser, F
Bozec, L
Zeghari-Squalli, N
Misset, JL
Citation: F. Goldwasser et al., Cellular pharmacology of the combination of oxaliplatin with topotecan in the IGROV-1 human ovarian cancer cell line, ANTI-CANC D, 10(2), 1999, pp. 195-201
Authors:
Wasserman, E
Cuvier, C
Lokiec, F
Goldwasser, F
Kalla, S
Mery-Mignard, D
Ouldkaci, M
Besmaine, A
Dupont-Andre, G
Mahjoubi, M
Marty, M
Misset, JL
Cvitkovic, E
Citation: E. Wasserman et al., Combination of oxaliplatin plus irinotecan in patients with gastrointestinal tumors: Results of two independent phase I studies with pharmacokinetics, J CL ONCOL, 17(6), 1999, pp. 1751-1759
Authors:
Goldwasser, F
Bae, I
Pommier, Y
Fornace, AJ
Citation: F. Goldwasser et al., Evidence of a reduced DNA topoisomerase II mRNA expression after ionizing radiation, ANTICANC R, 19(4B), 1999, pp. 3167-3171
Risultati:
1-14
|